Literature DB >> 8302054

Outcome measures for the neonatal management of pulmonary atresia with intact ventricular septum.

C Bull1, M Kostelka, K Sorensen, M de Leval.   

Abstract

The outcome in 135 patients with pulmonary atresia with intact ventricular septum was reviewed in terms of actuarial survival and "suitability" for eventual definitive repair (defined as having a tricuspid valve diameter larger than 2.4 standard deviations below the mean normal beyond the neonatal period). Of patients who underwent an initial closed valvotomy, 50% were dead, 22% were alive and suitable, and the remaining 28% were alive but unsuitable for definitive repair at 5 years. None of 66 patients who underwent primary shunt alone achieved suitability and 52% were dead at 5 years. No mode of neonatal closed valvotomy was consistently satisfactory: in only 10 of 26 survivors with serial measurements did the neonatal valvotomy alone achieve decompression to subsystemic pressures. Only half of the decompressed ventricles achieved growth of the tricuspid valve disproportionate to somatic growth as a result of the neonatal procedure. Strategies for the neonatal treatment of pulmonary atresia with intact ventricular septum should not rely on closed operations on the pulmonary valve to optimized right ventricular growth.

Entities:  

Mesh:

Year:  1994        PMID: 8302054

Source DB:  PubMed          Journal:  J Thorac Cardiovasc Surg        ISSN: 0022-5223            Impact factor:   5.209


  10 in total

1.  Hemodynamic assessment in patients with one-and-a-half ventricle repair revealed by four-dimensional flow magnetic resonance imaging.

Authors:  Sergio Uribe; Pablo Bächler; Israel Valverde; Gérard R Crelier; Philipp Beerbaum; Cristian Tejos; Pablo Irarrazaval
Journal:  Pediatr Cardiol       Date:  2012-03-25       Impact factor: 1.655

Review 2.  Biventricular repair versus uni-ventricular repair for pulmonary atresia with intact ventrical septum: A systematic review.

Authors:  Fei-Fei Li; Xin-Ling Du; Shu Chen
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2015-10-22

3.  Importance of right ventricular outflow tract angiography in distinguishing critical pulmonary stenosis from pulmonary atresia.

Authors:  K P Walsh; J M Abdulhamed; J P Tometzki
Journal:  Heart       Date:  1997-05       Impact factor: 5.994

4.  Evolution of the management approach for pulmonary atresia with intact ventricular septum.

Authors:  Y P Mi; A K T Chau; C S W Chiu; T C Yung; K S Lun; Y F Cheung
Journal:  Heart       Date:  2005-05       Impact factor: 5.994

5.  Prenatal diagnosis of right ventricular outflow tract obstruction with intact ventricular septum, and detection of ventriculocoronary connections.

Authors:  Y V Maeno; C Boutin; L K Hornberger; B W McCrindle; T Cavallé-Garrido; G Gladman; J F Smallhorn
Journal:  Heart       Date:  1999-06       Impact factor: 5.994

6.  Long-term outcome for right heart function after biventricular repair of pulmonary atresia and intact ventricular septum.

Authors:  A Mishima; M Asano; S Sasaki; S Yamamoto; T Saito; T Ukai; Y Suzuki; T Manabe
Journal:  Jpn J Thorac Cardiovasc Surg       Date:  2000-03

Review 7.  Surgical strategy for pulmonary atresia with intact ventricular septum: initial management and definitive surgery.

Authors:  Naoki Yoshimura; Masahiro Yamaguchi
Journal:  Gen Thorac Cardiovasc Surg       Date:  2009-07-14

8.  Complete atresia of coronary ostia in pulmonary atresia and intact ventricular septum.

Authors:  S E Selamet; D T Hsu; H M Thaker; W M Gersony
Journal:  Pediatr Cardiol       Date:  2003-09-04       Impact factor: 1.655

9.  Laser valvotomy with balloon valvoplasty for pulmonary atresia with intact ventricular septum: five years' experience.

Authors:  J L Gibbs; M E Blackburn; O Uzun; D F Dickinson; J M Parsons; R R Chatrath
Journal:  Heart       Date:  1997-03       Impact factor: 5.994

10.  Fetal intervention in right outflow tract obstructive disease: selection of candidates and results.

Authors:  E Gómez Montes; I Herraiz; A Mendoza; A Galindo
Journal:  Cardiol Res Pract       Date:  2012-08-15       Impact factor: 1.866

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.